Recall image placeholder

No image published for this recall

Baxter Cefazolin in Dextrose Injection - safety alert

Official notice

24 Jul 2026

Last checked

24 Jul 2026

Risk not stated by sourceFDA
Watch Baxter

An official FDA notice concerns Baxter Cefazolin in Dextrose Injection - safety alert. An official FDA notice concerns Cefazolin in Dextrose Injection. The notice reports a potential product safety risk. Follow the official notice for consumer instructions. Published 2026-07-24. Lots: LD175708, Exp. Check the official notice for the complete list. Published 2026-07-24.

What to do now

The source does not provide specific consumer instructions. Follow the official FDA notice for next steps.

Official notice

2026-07-24

The hazard

An official FDA notice concerns Cefazolin in Dextrose Injection. The notice reports a potential product safety risk. Follow the official notice for consumer instructions. Published 2026-07-24. Lots: LD175708, Exp. Check the official notice for the complete list.

How to check if you're affected

Compare the VIN on your vehicle against the official list. If your VIN is listed, follow the official notice.

Lots

LD175708, Exp

Checked manually this time?

The app watches your VIN and alerts you automatically next time — no searching, no checking back.

Turn on automatic VIN checks

Affected products

Product 1

Cefazolin in Dextrose Injection

Risk / hazard

An official FDA notice concerns Cefazolin in Dextrose Injection. The notice reports a potential product safety risk. Follow the official notice for consumer instructions. Published 2026-07-24. Lots: LD175708, Exp. Check the official notice for the complete list.

Where it was sold

The source does not list specific retailers. See the official notice for where affected vehicles were sold.

Location 1

US · United States

Affected area 1

US · United States

Company & contacts

Brand

Baxter

Manufacturer

Not provided

Phone

1-800-332-1088, (888) 229-0001, (224) 948-5353

Brand: Baxter. Contact: Baxter International Inc.. Phone 1-800-332-1088, (888) 229-0001, (224) 948-5353.

Source & status

Source

Tier

official

Category

HEALTH

App estimate

unspecified

Recall details

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

US
Recall image placeholder

Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL - safety alert

Medium riskFDA27 Jul 2026
US
Recall image placeholder

a product listed in the official notice - safety alert

mediumFDA28 Apr 2026

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 24 Jul 2026. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.